Lensing, Anthonie W. A.
Male, Christoph
Young, Guy
Kubitza, Dagmar
Kenet, Gili
Patricia Massicotte, M.
Chan, Anthony
Molinari, Angelo C.
Nowak-Goettl, Ulrike
Pap, Ákos F.
Adalbo, Ivet
Smith, William T.
Mason, Amy
Thelen, Kirstin
Berkowitz, Scott D.
Crowther, Mark
Schmidt, Stephan
Price, Victoria
Prins, Martin H.
Monagle, Paul
Funding for this research was provided by:
Bayer AG (N/A)
Janssen Research and Development (N/A)
Article History
Received: 5 October 2018
Accepted: 19 November 2018
First Online: 21 December 2018
Ethics approval and consent to participate
: Study sponsors and investigators agreed to abide by Good Clinical Practice guidelines and under the guiding principles detailed in the Declaration of Helsinki, and in accordance with any applicable local law(s) and regulation(s). Documented approval from appropriate Independent Ethics Committees/Institutional Review Boards was obtained for all participating centers/countries prior to the start of the study, according to Good Clinical Practice, local laws, regulations and organizations. As a requirement for participation, informed consent will be asked from the parent(s)/legal guardian(s) and, if appropriate as determined by local regulation, age and individual child capability, child assent will be sought, according to country-specific regulations.
: Not applicable.
: AWAL, DK, AFP, IA, WTS, AM, and KT are employees of Bayer AG. CM has received consulting fees from Bayer and Bristol-Myers Squibb, and lecture fees from Bayer. GK has received research funding from Pfizer and receives consulting and lecture fees from Daichi Sankyo. MPM has received consulting fees from Bayer. AC has received consulting fees from Bayer, Daiichi Sankyo, and Pfizer/Bristol-Myers Squibb. ACM has received consulting fees from Bayer, CSL Behring, Kedrion, NovoNordisk, Pfizer, Shire, and SOBI. UNG has received consulting fees from Bayer, Boehringer, Octapharma, LFB, and SOBI. MG has received consulting fees from Bayer, Shionogi, Octapharma, Bristol-Myers Squibb Canada, and Daiichi Sankyo, and lecture fees from Pfizer, Alexion, and CSL Behring. SS has received consulting fees from Bayer. MHP has received consulting fees from Bayer, Pfizer, and Daiichi Sankyo. GY, VP, and PM declare no competing financial interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.